Provexis, announced the resignation of Frédéric Boned, a Non-executive Director of the Company, with immediate effect. Frédéric Boned joined the Board of Provexis as a Non-executive Director in July 2018, at which point he was EMEA Vice President of DSM's Human Nutrition & Health business, a part of DSM Nutritional Products. Frédéric, who is currently Regional Vice President Health Nutrition & Care North America at DSM, has announced his resignation from DSM with effect from 15 October 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6 GBX | 0.00% | 0.00% | -7.69% |
Apr. 03 | Quiz sales fall, names new CEO; Byotrol eyes AIM exit | AN |
2023 | Provexis plc Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-7.69% | 16.91M | |
+8.20% | 7.78B | |
+1.64% | 7.38B | |
+10.20% | 6.52B | |
-8.10% | 3.67B | |
-14.57% | 1.17B | |
+8.34% | 934M | |
-42.27% | 879M | |
-18.90% | 836M | |
-16.45% | 802M |
- Stock Market
- Equities
- PXS Stock
- News Provexis plc
- Provexis plc Announces Directorate Change